
Asia Pacific Academy of Science Pte. Ltd. (APACSCI) specializes in international journal publishing. APACSCI adopts the open access publishing model and provides an important communication bridge for academic groups whose interest fields include engineering, technology, medicine, computer, mathematics, agriculture and forestry, and environment.

MiR-325-5p Targets HDAC3 to Protect Early Brain Injury in Subarachnoid Hemorrhage via NF-κB Signal Pathway
Vol 37, Issue 5, 2023
Abstract
Objective: To explore miR-325-5p expression after subarachnoid hemorrhage (SAH) and its impact on early brain injury in SAH rats. Methods: Forty-eight male Sprague-Dawley (SD) rats were used in this study, 12 in the sham group, 12 in the SAH group, 12 in the SAH+miR-325-5p mimic group, and 12 in SAH+miR-325-5p mimic+oe-HDAC3 group. The SAH model was established using a common occipital cistern secondary blood injection. Brain water content and SAH grades were measured. Quantitative real time reverse transcription polymerase chain reaction (qRT-PCR) assay was used to measure miR-325-5p expression. Apoptosis was assessed by flow cytometry. Cell Counting Kit-8 (CCK8) assay was used to examine cell proliferation. Luciferase reporter assay was used to confirm the relationship between miR-325-5p and HDAC3 (histone deacetylase 3). Results: MiR-325-5p expression decreased in the SAH rats and oxyHb induced PC12 cells. Apoptosis decreased induced by miR-325-5p mimic. Cell proliferation significantly increased, and inflammation related protein level was inhibited in the miR-325-5p mimic group. MiR-325-5p was predicted to specifically combine with the HDAC3 3′UTR region using the targetscan. MiR-325-5p mimic significantly regulated HDAC3-wt activity and HDAC3 level was lower in the miR-325-5p mimic group. Furthermore, overexpressed HDAC3 reversed miR-325-5p protecting effects on early brain injury (EBI) in SAH. Conclusions: MiR-325-5p targeted HDAC3 to protect early brain injury in SAH via NF-κB signal pathway.
Keywords
References
Supporting Agencies
Copyright (c) 2023 Fanliang Meng
This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Medical Genetics, University of Torino Medical School, Italy

Department of Biomedical, Surgical and Dental Sciences, University of Milan, Italy